ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Interest Income

Income earned on cash, deposits, and investments held by the company.

No reported Interest Income figures are available to summarize.

Interest Income history

Currency unavailable · from the income statement

No Interest Income data reported for this period type.

Interest Income vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Interest Income for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WVEWave Life Sciences Ltd.LTM Mar 2026$12.89M USD+22.8%—18.0%
STOKStoke Therapeutics, Inc.LTM Mar 2026$10.88M USD-17.0%+64.0%33.9%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$9.27M USD-47.9%+57.6%20.4%
PRMEPrime Medicine, Inc.LTM Mar 2026$4.98M USD+23.6%—123.4%
BNTCBenitec Biopharma Inc.LTM Mar 2026$1.59M USD-3.2%——
MGTXMeiraGTx Holdings plcLTM Mar 2026$1.04M USD-74.2%+32.8%1.3%
PRQRProQR Therapeutics N.V.LTM Mar 2026€852.58K EUR-60.2%+176.5%6.3%
SLNSilence Therapeutics plcLTM Mar 2026$0 USD—+148.8%0.0%
RNAAtrium Therapeutics, Inc.FY2025$0 USD——0.0%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-17.0%+64.0%12.2%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.